These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15101567)
1. Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Drimer T; Shahal B; Barak Y Int Clin Psychopharmacol; 2004 Jan; 19(1):27-9. PubMed ID: 15101567 [TBL] [Abstract][Full Text] [Related]
2. Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. Ogino S; Miyamoto S; Tenjin T; Kitajima R; Ojima K; Miyake N; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Tatsunami S; Kubota H; Kaneda Y; Yamaguchi N Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):78-83. PubMed ID: 20828595 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191 [TBL] [Abstract][Full Text] [Related]
4. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients. Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855 [TBL] [Abstract][Full Text] [Related]
5. Effects of trihexyphenidyl on MMSE and CAMCOG scores of medicated elderly patients with schizophrenia. Heinik J Int Psychogeriatr; 1998 Mar; 10(1):103-8. PubMed ID: 9629529 [TBL] [Abstract][Full Text] [Related]
6. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic. Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880 [TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interaction in Mexican patients with schizophrenia. Ocaña-Zurita MC; Juárez-Rojop IE; Genis A; Tovilla-Zárate CA; González-Castro TB; Lilia López-Narváez M; de la O de la O ME; Nicolini H Int J Psychiatry Clin Pract; 2016 Nov; 20(4):249-53. PubMed ID: 27552677 [TBL] [Abstract][Full Text] [Related]
8. Intravenous biperiden in akathisia: an open pilot study. Hirose S; Ashby CR Int J Psychiatry Med; 2000; 30(2):185-94. PubMed ID: 11001281 [TBL] [Abstract][Full Text] [Related]
9. The effect of the muscarinic M Vingerhoets C; Bakker G; van Dijk J; Bloemen OJN; Wang Y; Chan RCK; Booij J; van Amelsvoort TAMJ Eur Neuropsychopharmacol; 2017 Sep; 27(9):854-864. PubMed ID: 28689687 [TBL] [Abstract][Full Text] [Related]
10. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine. Mulsant BH; Gharabawi GM; Bossie CA; Mao L; Martinez RA; Tune LE; Greenspan AJ; Bastean JN; Pollock BG J Clin Psychiatry; 2004 Dec; 65(12):1708-14. PubMed ID: 15641877 [TBL] [Abstract][Full Text] [Related]
11. Effect of anticholinergics on tardive dyskinesia. A controlled discontinuation study. Greil W; Haag H; Rossnagl G; Rüther E Br J Psychiatry; 1984 Sep; 145():304-10. PubMed ID: 6148119 [TBL] [Abstract][Full Text] [Related]
12. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]. Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G; Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055 [TBL] [Abstract][Full Text] [Related]
13. Biperiden Selectively Impairs Verbal Episodic Memory in a Dose- and Time-Dependent Manner in Healthy Subjects. Borghans L; Sambeth A; Blokland A J Clin Psychopharmacol; 2020; 40(1):30-37. PubMed ID: 31834098 [TBL] [Abstract][Full Text] [Related]
14. Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients. A Double-blind cross-over study. Silver H; Geraisy N Br J Psychiatry; 1995 Feb; 166(2):241-3. PubMed ID: 7728369 [TBL] [Abstract][Full Text] [Related]
15. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group. Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567 [TBL] [Abstract][Full Text] [Related]
16. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study. Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570 [TBL] [Abstract][Full Text] [Related]
17. Recurrent paroxysmal episodes characterized by perceptual alteration in three schizophrenic patients on neuroleptic medication. Higuchi H; Shimizu T; Hishikawa Y Psychiatry Clin Neurosci; 1997 Jun; 51(3):99-101. PubMed ID: 9225371 [TBL] [Abstract][Full Text] [Related]
18. Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia. Desmarais JE; Beauclair L; Annable L; Bélanger MC; Kolivakis TT; Margolese HC Ther Adv Psychopharmacol; 2014 Dec; 4(6):257-67. PubMed ID: 25489477 [TBL] [Abstract][Full Text] [Related]
19. Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment? Desmarais JE; Beauclair L; Margolese HC J Psychopharmacol; 2012 Sep; 26(9):1167-74. PubMed ID: 22651987 [TBL] [Abstract][Full Text] [Related]
20. Biperiden for excessive sweating from clozapine. Richardson C; Kelly DL; Conley RR Am J Psychiatry; 2001 Aug; 158(8):1329-30. PubMed ID: 11481174 [No Abstract] [Full Text] [Related] [Next] [New Search]